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CHAPTER 1 
 
LITERATURE REVIEW 
 
INTRODUCTION 
 
The role of the endoscope as a relatively newer technique in the management of 
cholesteatoma has sparked relevant debates among ear surgeons. Endoscopic ear surgery 
might have gained acceptance in its role as a complementary tool to microscopic ear surgery 
but perhaps not so much as an instrument for exclusive use. To review outcomes of this 
surgical tool, existing literature on endoscopic cholesteatoma ear surgery was reviewed.  
There is a consensus in literature regarding the objective of cholesteatoma surgery, which is 
complete disease clearance to keep the ear safe and dry1. 
Researchers have made considerable advances in our understanding of cholesteatoma 
etiopathogenesis at molecular level; however, a non-surgical treatment capable of completely 
eradicating cholesteatoma is yet to be developed. Complete disease eradication can only be 
achieved through surgical techniques; however, proper patient selection is important. 
Before the emergence of endoscopes, the microscope was a widely used surgical tool in 
cholesteatoma surgery. Many otologic surgeons remain accustomed to it. The advantages of 
the operative microscope still make it invaluable even in the era of this newer technique. To 
mention a few: good quality view of the middle ear, mastoid and the temporal bone anatomy 
and pathology adds to its value; and it affords the surgeon the freedom to use both hands 
during surgery to clear the surgical field for better visualization while clearing the pathology2. 
Its main limitation has been reported as the inability to look around corners, with concerns of 
possibly missing pathology in the deeper recesses of the middle ear such as the sinus 
tympani, facial recess and the attic2,3. As a result, this necessitates soft tissue retraction and 
drilling for adequate exposure.  
Since the 1990’s, operative endoscopy was introduced in ear surgery by Thomassin et al4, 
with the objective of using it as a complementary tool to the microscope5. It has since been 
believed to improve visualization during cholesteatoma surgery and has been gaining 
acceptance. 
Literature defines “exclusive endoscopic ear surgery” as the sole use of the rigid endoscope 
to visualize and facilitate middle ear surgery4. It is a minimally invasive approach which is 
indicated for cholesteatoma not extending beyond the confines of the tympanic cavity5. There 
is currently insufficient data on recidivism and hearing outcomes following exclusive 
endoscopic use in cholesteatoma ear surgery5.  
Reports have shown the endoscope to be a superior tool for detecting cholesteatoma hotspots 
without removal of bone and unnecessary soft tissue stripping3-6. With endoscopic ear 
surgery (EES), patient morbidity has been reduced by avoidance of skin incisions, reduced 
need for drilling, less postoperative pain and reduced hospital stay4,5. Its cost effectiveness 
has been found to be comparable to microscopic use5.  
Some pitfalls of EES are well described in literature and include using one hand to hold the 
scope while the other performs surgery1 and looking at the screen while operating, which 
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could result in inability to judge the distance between the scope and the surgical plane3. 
Concerns regarding the safety of the endoscope as a surgical tool have been raised, 
particularly with regard to possible thermal injury, especially when the xenon light is used. 
Other concerns like fogging of the scope and ear trauma in case of accidental movement add 
to the drawbacks of this technique. 
In some instances, the use of both the microscope and the endoscope has been advocated 
when dealing with cholesteatoma near high-risk middle ear structures such as the facial 
nerve7. 
Studies looking at outcomes of exclusive endoscopic approach in cholesteatoma surgery are 
few and long-term follow-up of patients for recidivism is short, particularly when looking at 
recurrent disease8.  
LITERATURE SEARCH  
 
The aim of the research study was to address the hypothesis that “endoscopic ear surgery 
offers equivalent, if not better surgical outcomes, compared to microscopic ear surgery in the 
surgical management of cholesteatoma. Journal articles were obtained through the PubMed 
central library by inserting the search words “endoscopic ear surgery”, “ cholesteatoma ear 
surgery ” and “cholesteatoma recidivism”. Articles reporting on outcomes of endoscopic ear 
surgery, microscopic ear surgery, and combined techniques written in English were selected. 
Seventeen articles were found to be relevant to this study. 
 
SUMMARY AND INTERPRETATION OF LITERATURE 
 
Endoscopic ear surgery is a newer technique and there is paucity in the literature on outcomes 
of its exclusive use in cholesteatoma surgery, and as a complementary tool for microscopic 
approaches. No studies were found comparing recidivism outcomes of all four known 
surgical techniques described in the literature, namely: exclusive endoscopic surgery (EES), 
microscopic canal wall up (CWU), microscopic canal wall down (CWD) and combined 
endoscopic-microscopic techniques. 
 
There is consensus in the literature regarding the objective of cholesteatoma surgery, which is 
complete disease resection to keep the ear safe and dry1. Historically, the management of 
cholesteatoma was either approached using microscopic canal wall up or microscopic canal 
wall down techniques. The decision on which approach to use is based on a number of factors 
which include: the extent of the disease, pneumatisation of the mastoid, aeration of the 
middle ear and mastoid, reliability of patient follow-up and the surgeon’s preference. It is 
well known that a canal wall up technique has a much higher recidivism rate compared to a 
canal wall down technique1. 
A Canadian study found that 70% of ear surgeons used an endoscope for cholesteatoma 
surgery9, either exclusively or as a complementary tool . Then a systematic review looked at 
outcomes of 11 EES studies in cholesteatoma surgery2. In all of them, the endoscope was 
found to be useful for visualization and facilitation of cholesteatoma eradication. These 
studies however had low evidence follow-up data due to short time of follow-up (mean 
follow-up period of 23 months) and the limited number of patients treated by the authors. In 
fact, with the exception of Tarabichi11, there is no report showing a follow-up period greater 
than three years. In terms of patient numbers, only Marchioni et al.8 reported a cohort larger 
than 100 patients.  
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Analysing the articles chosen for their review, it can be noted that three authors (Tarabichi, 
Migirov and Barakate) exclusively performed transcanal endoscopic surgeries, while in the 
other five reports, a combined technique was also applied if necessary. Overall, exclusive 
endoscopic management of the pathology was obtained in 293 (57%) cases, while 224 (43%) 
operations were performed with a combined technique. During the follow-up period, a total 
of 48 patients showed residual pathology: in particular, 32 patients had residual disease, 
while 16 patients presented with a recurrence of cholesteatoma. Conversion from endoscopic 
approach to microscope use in these studies occurred in up to 23% of cases3. Marchioni et al.8 
published an article looking at the exclusive endoscopic approach to cholesteatoma in the 
paediatric population. In this study, 59 cases were included, with 31 endoscopic approaches 
and 28 patients underwent a combined approach. Their recidivism rate was 13% for the EES 
group and 17% for the combined group. Of note was that the microscope had missed 17% of 
residual cholesteatoma. The sites of residual disease are however not stated in their article. 
Published data also showed CWU residual rate of 20 % versus 7% in CWD procedures10. 
Gaillardin’s study found cholesteatoma residual rates of 25% with CWU procedures over a 4 
year follow-up. Mishiro et al.12 observed higher recidivism of 19.4% after lowering the canal 
wall, this concurred with a study by Haginomori13. Over a follow-up period ranging from 4 to 
15 years (mean follow-up of 8 years), de Zinis et al. observed only 4 (2.1%) residual 
cholesteatomas and no recurrent cholesteatomas among 189 ears treated with a CWD 
procedure for cholesteatoma of the middle ear. Sanna et al. evaluated 222 cases of 
cholesteatomas operated with their modified Bondy’s technique, they reported a pearl-like 
residual cholesteatoma in 7.4% of ears, while no recurrences were discovered over a mean 
follow-up period of 7.8 years (range, 5-16 years).  
Mishiro12 also observed that the methods used for statistical analysis, among other factors, 
determined recidivism rates, and therefore advocated for the use of Kaplan-Meir survival 
analysis. In their meta-analysis performed on 13 studies including a total of 4720 patients, 
Tomlin et al.14 demonstrated that, when performed as a single-stage surgery, an intact canal 
wall approach to cholesteatoma treatment had nearly 3 times greater likelihood of recurrence 
than a canal wall down surgery. In our study there was a 7 times likelihood of recurrence with 
a CWU procedure. In general, only 2 of the studies reported no significant differences 
between the two techniques. Regarding the data in their review, the high rate of exclusive 
endoscopic trans-canal procedures performed (57%), should be noted in comparison with the 
lower rate of combined approaches requiring mastoidectomy (43%). Another point of interest 
was the rate of residual disease and recurrences that appear lower compared to data reported 
in the literature for canal wall up interventions performed exclusively by microscopy. These 
promising results seemed to confirm the usefulness of the endoscope in terms of outcomes.  
A study by Mohammad Ajalloueyan et al.15 showed that adding the use of an endoscope to 
any surgical approach in cholesteatoma surgery lowers recidivism and improves hearing 
results. Similarly, Hamed et al.16 also found in their study that bringing in an endoscope at the 
end of a microscopic procedure reduces risk of leaving behind any residual disease.  
Finally, a case series by  Cohen et al17looked at residual rates in elective second-look 
operations in children during planned second-look procedures following primary 
cholesteatoma resection using endoscopic and microscopic operative approaches. Case series 
looking at outcomes from paediatric patients undergoing cholesteatoma surgery from January 
2011 through August 2015 were analysed. Cholesteatoma extent at initial resection was 
staged, and comparison among endoscopic dissection and microscopic or 
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endoscopic inspection groups was made. Presence of disease at the time of planned second-
look was quantified and a descriptive analysis performed. Fifty-five patients (56 ears) with 
planned second-look procedures were included and underwent a total of 120 procedures. The 
median age was 11 years. Endoscopes were used for inspection in 25 (39%) primary 
resections and for dissection in 39 (61%) primary resections. Extent of the disease at the time 
of primary resection was similar among groups. Cases where the endoscope was used for 
inspection only or not at all during primary resection had a 24% rate of residual 
cholesteatoma at the time of second-look compared with a 23% rate for cases with 
endoscopic resection. Rate of mastoidectomy significantly decreased from 63% to 33% over 
the study period (P = 0.04), with similar disease extent (P = 0.99), but residual cholesteatoma 
rates during planned second-look procedures were similar between the study groups. 
Unnecessary mastoidectomies were reduced to over 30% just by bringing in the endoscope. 
CONCLUSION  
Eradication of cholesteatoma and restoration of hearing function presents unique surgical 
challenges. Exclusive endoscopic approach for cholesteatoma surgery appears to have 
recidivism rates that are comparable to classic microscopic CWU approaches, with the added 
benefit of conservative surgery and possibly a shorter average operating time compared with 
a traditional postauricular approach. 
The exclusive endoscopic approach now represents a feasible, minimally invasive technique 
for the management of middle ear cholesteatoma. Endoscopes do play a useful role as 
adjuncts to microsurgery in the visualization of hidden areas and with confirming disease 
eradication, and an added benefit of a reducing the need for mastoidectomy.  
CWD is now reserved for larger cholesteatoma or for unfavourable anatomic conditions. The 
choice to perform a CWD is often intraoperative and related to anatomical conditions that do 
not allow safe cholesteatoma removal, i.e. a low-lying middle cranial fossa dura, an anteriorly 
positioned sigmoid sinus which creates a small mastoid, and limited access into the anterior 
epitympanum for the presence of a perilymphatic fistula.  
Limitations related to the studies analysed are short period of follow-up, small patient 
numbers and the absence of randomized trials. 
AREAS FOR FUTURE RESEARCH 
Studies with a long-term follow up and larger cohort studies are necessary to definitively 
validate the outcomes of the different techniques in cholesteatoma surgery, for a more 
meaningful conclusion. Studies looking at correct patient selection for the different surgical 
method would add quality and standardized approaches. None of the papers considered in this 
study were randomized trials, so there is always room for bias.  
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ABSTRACT 
 
Background: Endoscopic ear surgery has gained acceptance as a complementary tool to 
microscopic ear surgery, but perhaps not so much as an instrument for exclusive use.With 
this approach becoming popular, there is scarce data on cholesteatoma recidivism and hearing 
outcomes, when exclusively used. 
Objectives: Auditing outcomes of endoscopic ear surgery for the surgical management of 
cholesteatoma in the Groote Schuur hospital (above13 year age group) and the Red Cross 
War Memorial Children’s hospital (below 13 year age group) , with a secondary aim of 
comparing recidivism and hearing outcomes of 4 different surgical techniques for 
cholesteatoma resection, namely, exclusive endoscopic (EES), microscopic canal wall down 
(CWD), microscopic canal wall up (CWU) and combined endoscopic-microscopic 
techniques. 
Methods: A retrospective chart review was conducted at our two tertiary academic referral 
hospitals in Cape Town, namely, Red Cross War Memorial Children’s Hospital and Groote 
Schuur Hospital from January 2012 to December 2016. 
Results: A total of 128 cholesteatoma ear surgeries were done; 110 patients were above the 
age of 13 years and 18 patients were below the age of 13 years. Eight Red Cross patients 
underwent EES, 7 had CWU, 2 had CWD and 1 had a combined technique. Overall 
recidivism rate in this population was 33% (6/18), of which 2 were approached exclusively 
endoscopically, 2 underwent a microscopic CWU, 1 had a CWD and 1 had combined 
endoscopic-microscopic approach. The mean postoperative hearing in this group was 40dB 
compared to a preoperative mean of 50,3 decibels (dB). In the Groote Schuur group, 23 
underwent an exclusive endoscopic approach; 42 had a CWU, 40 had a CWD and 5 had a 
combined endoscopic-microscopic approach. Overall recidivism rate for the above 13 year 
old group was 17% (19/110). Of those, 7 were from the endoscopic group, 8 from the CWU 
group, 1 from CWD group and 3 from the combined technique group. Mean postoperative 
hearing was 47,4dB compared to a preoperative hearing of 48,4dB.  
 
Conclusions: The CWD technique demonstrated superior outcomes in both the above and 
below 13 year age groups. In the above 13 year old group, the EES approach had the same 
recurrence rate as CWU. While paediatric cholesteatomas have much higher recidivism rates 
compared to adults, our below 13 year old group was too small to conclude any statistical 
significant differences between the different approaches, and therefore, further studies are 
required in this age group. Management of cholesteatoma requires a highly individualized 
approach that takes into account anatomic, clinical and social factors to determine the most 
appropriate surgical treatment paradigm. 
Keywords: Cholesteatoma; endoscopic ear surgery; cholesteatoma surgery; recidivism; 
outcomes 
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List of abbreviations 
RCWMH: Red Cross War Memorial Hospital 
GSH: Groote Schuur Hospital 
ENT: Ear, Nose and Throat 
EES: Endoscopic ear surgery 
CT: Computerized Tomography 
MRI: Magnetic Resonance Imaging 
dB: Decibel 
AC: Air conduction 
BC: Bone conduction 
PTA: Pure Tone Average 
CWU: Canal wall up 
CWD: Canal wall down 
 12 
INTRODUCTION  
The objective of cholesteatoma surgery is complete disease resection to keep the ear safe and 
dry1.  
Before the arrival of endoscopes, the microscope was a widely used surgical tool in 
cholesteatoma surgery. Many otologic surgeons preferred using it. Certain advantages of the 
operative microscope still make it invaluable even in the era of the newer endoscopic 
technique. Amongst other advantages, the microscope is known for its good quality view of 
the middle ear, mastoid and temporal bone anatomy and pathology; and it affords the surgeon 
the freedom to use both hands during surgery2. Its main limitation is its inability to look 
around corners, with concerns of possibly missing pathology in the deeper recesses of the 
middle ear such as the sinus, tympani, facial recess and the attic2,3. As a result, this may 
necessitate soft tissue retraction and drilling for adequate exposure. 
Endoscopic ear surgery has gained acceptance in its role as a complementary tool to the 
microscope, but perhaps not so much as a technique for exclusive use in cholesteatoma 
surgery. To improve understanding of this technique, existing literature on endoscopic 
cholesteatoma ear surgery was thoroughly reviewed.  
Operative endoscopy was introduced in ear surgery in the 1990’s by Thomassin4, with the 
objective of using it as a complementary tool to the microscope5. Over the years, this 
technique has been widely gaining acceptance. Literature defines exclusive endoscopic ear 
surgery as the sole use of the rigid endoscope to visualize and facilitate middle ear surgery4.  
It is a minimally invasive approach which is indicated for cholesteatoma not extending 
beyond the confines of the tympanic cavity5.  
There is currently insufficient data on recidivism and hearing outcomes following exclusive 
endoscopic use in cholesteatoma ear surgery5. It has been reported to improve visualization 
during cholesteatoma surgery. Reports have shown the endoscope to be a superior tool in 
detecting cholesteatoma hotspots, without the need to remove excessive bone, and avoiding 
unnecessary need for soft tissue stripping3-6. With EES patient morbidity has been directly 
reduced by avoiding skin incisions, reduced need for drilling, less postoperative pain and 
reduced hospital stay4,5. Its cost effectiveness has been found to be comparable to the 
microscope 5.  
Some pitfalls of EES are well described in literature and includes using one hand1 to hold the 
scope, while the other performs surgery, and looking at the screen when operating which 
could result in an inability to judge the distance between the scope and the surgical plane3. 
Concerns regarding safety of the endoscope as a surgical tool have been raised, and this 
includes possible thermal injury especially when xenon light is used. Fogging of the scope 
and ear trauma in case of accidental head movement adds to the drawbacks of this technique. 
In certain cases, the use of both the microscope and the endoscope is advisable when dealing 
with cholesteatoma near high-risk middle ear structures such as the facial nerve7. 
Studies looking at outcomes of cholesteatoma surgery exclusively using the endoscope are 
few and long-term follow-up was found to be short8.  
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OBJECTIVES 
The objective of this study was to audit outcomes of endoscopic ear surgery for the surgical 
management of cholesteatoma in the group above 13 years of age and the group less than 13 
years of age; with a secondary aim of comparing recidivism and hearing outcomes of 4 
different surgical techniques for cholesteatoma, namely, exclusive endoscopic (EES), 
microscopic canal wall down (CWD), microscopic canal wall up (CWU) and the combined 
endoscopic-microscopic techniques. 
MATERIALS AND METHODS 
Definitions 
? Cholesteatoma is a growth of abnormal keratinizing squamous epithelium with 
accumulation of squamous debris in the middle ear cleft and can be either congenital 
or acquired9. 
? Recurrent cholesteatoma is defined as a new cholesteatoma developing from a 
newly formed, non-self-cleaning retraction pocket10.  
? Residual cholesteatoma is defined as cholesteatoma left behind during initial 
surgery10.  
? Recidivism refers to both residual and recurrent disease. 
? Endoscopic ear surgery is defined as the use of the rigid endoscope to perform ear 
surgery4. 
? Canal wall up mastoidectomy refers to exenteration of the mastoid air cells with 
preservation of the posterior external canal wall 9. 
? Canal wall down mastoidectomy refers to the exenteration and exteriorization of the 
mastoid air cells by removal of the posterior external ear canal wall9. 
? Combined endoscopic-microscopic cholesteatoma ear surgery refers to use of both 
the microscope and the endoscope for eradication of cholesteatoma. The endoscope 
may be employed either just for visualization to ensure that the disease has been 
eradicated after resection has been done microscopically, or the endoscope may be 
used at the start for resection of cholesteatoma confined to the middle ear and attic but 
then converted to microscopic approach when the disease extends beyond the 
posterior limit of the lateral semicircular canal. This is the approach adopted for 
combined procedures at our institutions 
Study Population 
The study was conducted at two tertiary academic hospitals in Cape Town, Red Cross War 
Memorial Children’s Hospital, which is our main referral center for patients under the age of 
13 years, and Groote Schuur Hospital, which serves as a major referral hospital for patients 
above the age of 13 years. For the purpose of this study, the study participants were classified 
into a category of less than 13 years of age and above 13 years of age. 
Study design 
A retrospective chart review was conducted of all patients who underwent primary surgery 
for cholesteatoma at Red Cross War Memorial Children’s Hospital and Groote Schuur 
Hospital between January 2012 and December 2016.  The study’s participants, 128 in total, 
were identified through the theatre booking books over the 5year period. Follow-up for 
assessing outcome was initially conducted at 3 months, 6 months and 12 months, followed by 
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6 monthly visits in the first year following surgery. The study population was divided into 
four groups, namely populations A, B, C and D. Population A comprised of patients 
presenting with cholesteatoma who underwent primary exclusive endoscopic cholesteatoma 
surgery, while population B included those who underwent primary microscopic canal wall 
up procedure. Population C had a primary microscopic canal wall down procedure and 
Population D underwent a primary combined endoscopic-microscopic approach at initial 
surgery. 
The following data was collected and summarized onto a data collection sheet (see 
appendices): 
? Age 
? Sex 
? Affected side 
? Number of previous cholesteatoma surgeries 
? Preoperative otoendoscopic-otomicroscopic findings 
? Preoperative CT scan findings: it was a prerequisite for all patients to have 
preoperative CT scans to determine the appropriate surgical method to use 
? Site of cholesteatoma 
? Integrity of ossicular chain 
? Degree of pneumatization (i.e. sclerotic, moderately well or well pneumatized) 
? Extent of opacification 
? Hearing outcomes looking at preoperative and postoperative air conduction (AC), 
bone conduction (BC), air-bone gaps (ABGs) and pure-tone averages (PTA) 
? Residual disease 
? Disease complications 
? Iatrogenic complications 
? Presence of otorrhoea 
 
Inclusion criteria 
 
? All patients who underwent primary surgery endoscopically or microscopically or 
both combined for cholesteatoma between the time period of January 2012 and 
December 2016  
? High resolution CT scan done pre-operatively 
 
Exclusion criteria 
? Cholesteatoma revision surgery 
? Patients without a pre-operative CT scan  
? Patients lost to follow-up were excluded, i.e. those who did not arrive for their 3 
months, 6 months and 12 months post-operative reviews 
 
STATISTICAL ANALYSIS 
Data was captured on a customized data collection sheet and entered into Microsoft Excel 
spreadsheet for analysis. Frequencies and proportions were used to describe categorical data. 
The Pearson chi-square test (or Fisher’s exact test where cell values were less than 5) was 
used to test the differences between groups or categories. All analysis was conducted in Stata 
version 13 (Stata Corp, College Station, Texas). All p-values <0.05 were considered 
statistically significant. 
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ETHICAL CONSIDERATIONS 
 
The study was approved by the University of Cape Town’s Departmental Research 
Committee of the Surgical specialties and ethical approval granted by the Research Ethics 
Committee, Faculty of Health Sciences, University of Cape Town ( HREC REF: 347/2017). 
 
RESULTS 
 
Baseline characteristics of study participants (Table 1.1) 
A total of 128 patients were included in the study of which 110 were from Groote Schuur 
Hospital and therefore >13 years of age, and 18 were from Red Cross Children’s Hospital 
and <13 years of age (age range for this group was 4 to 13 years). Of the 128 ears, 31 (24%) 
underwent an exclusive endoscopic surgical technique, 49 (38%) had a microscopic canal 
wall up procedure, 42 (33%) underwent a canal wall down procedure, with 6 (4%) having 
undergone a combined endoscopic-microscopic procedure. Twenty-three of 31 (74%) 
patients >13-year-old group had an exclusive endoscopic procedure, 42 of 49 (86%) had a 
microscopic canal wall up technique, 40 of 42 (95%) had a canal wall down procedure, and 5 
of 6 (83) underwent a combined endoscopic-microscopic procedure. Eight (26%) patients 
from the <13-year-old group underwent an exclusive endoscopic resection, 7 (14%) had a 
microscopic canal wall up procedure, 2 (5%) had a canal wall down mastoidectomy and 1 
(17%) underwent a combined endoscopic-microscopic procedure. There were 60 (47%) 
males and 68(53%) females. There was a slight predominance of involvement of 67 (52%) 
right sided ears and 61 (48%) left sided ears. All were unilateral with no bilateral 
involvement. The mean follow-up period was 29 months, with a range of 23-36 months.  
Site of cholesteatoma (Table 1.3) 
In the >13 year old group, the attic was the commonly involved primary site (58%) followed 
by extension of disease into mastoid in 47%, followed by disease extension into sinus 
tympani in 25% of cases. Prussak’s space was the fourth most frequently involved subsite 
(18% of cases) followed by extension into the facial recess (15%). Extension of disease into 
the hypotympanum was the least common (4%). 
When findings of the >13 year olds and <13 year olds were combined, the commonest site of 
cholesteatoma was the attic (66 of 128, which is 51.6%), followed by extension into mastoid 
(54 of 128, which is 43.2%), subsequently followed by extension into the sinus tympani (33 
of 128, which is 25.8%). Extension of disease into the facial recess and Prussak’s space had 
similar proportions (14.8%) and extension of the disease into the hypotympanum was the 
least common (4 of 128, which is 3.1%). See Figure 1.2.  
When looking exclusively at the <13 year old population, the overall distribution was slightly 
different. The attic and sinus tympani were the commonest sites (each 44.4%), followed by 
extension into the mastoid (38.9%), the facial recess (22.2%) and lastly Prussak’s space 
(5.6%). There were no lesions in the hypotympanum. Of note was that 60% of ears involved 
> than 2 sites. See Figure 1.3 and Table 1.4.  
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Outcomes by surgical technique 
In the >13 year old population, the recurrence rate was 17.3% and the proportion of 
recurrences by intervention mirrored that of the overall population.  
The lowest recidivism rate was seen in the canal wall down group (2.5%), with unfavourable 
outcomes noted in the combined endoscopic-microscopic group. A recidivism rate of 19% 
was seen in the microscopic CWU and 30% in the EES group. See table 2.1 and figure 2.2. 
The overall recidivism in the <13 year olds was higher at 33%,compared 17% for >13 year 
olds. In this group, recidivism was lowest in the exclusive endoscopic group (25%), followed 
by microscopic CWU with almost similar outcomes(28%). The highest recidivism rate was 
observed once again in the combined endoscopic-microscopic group(100%), followed by 
microscopic CWD recidivism (50%). The difference was not statistically significant 
(p=0.11). See table 2.2 and Figure 2.3. In this group however, the numbers were small to 
make any meaningful comparisons. The overall recurrence rate was 19.5% (25 of 128) when 
combining both the above and below 13 year old groups. This recurrence rate differed 
between the four  intervention groups and was found to be statistically significant (p=0.001). 
Recurrence was highest after the combined intervention (4 of 6, which is 66.7%) and lowest 
after CWD intervention (2 of 42, which is 4.8%). See figure 2.1. Overall, the attic was the 
commonest site of recidivism across the four different interventions (9 of 25, which is 36%) 
and the hypotympanum was the least affected. 
 
Site of recidivism 
The commonest site of recidivism for both groups was the attic and extension of disease into 
the mastoid, followed by disease extension into sinus tympani and into facial recess.  In the 
<13 year old group, the site of recidivism for microscopic CWU and combined endoscopic- 
microscopic approaches was confined to the attic, while recidivism in the exclusively 
endoscopic approach and microscopic CWU approaches extended into the mastoid. In the 
group >13 years, the site of recidivism for the exclusive endoscopic and microscopic CWU 
approach was confined to the attic, while disease extension into mastoid was seen with 
exclusive endoscopic and combined endoscopic-microscopic procedures (Table 2.1). 
 
Hearing outcomes 
 
In the <13 year age group, the mean postoperative hearing was 40dB, compared to a 
preoperative mean of 50,3dB. The change was much higher than that of the group >13 years 
of age (48.4dB). The overall hearing improvement post-operatively in the above 13 year olds 
seemed marginal(47,4dB post-operatively and 48,4 preoperatively) See figure 3.1. 
  
Fifty two (41%) had granulation tissue in the middle ear, while 90% had ossicular 
involvement, with the long process of incus being the most frequently eroded ossicle (53%), 
followed by stapes superstructure (24%).  
Analysing ossicular chain findings per technique, the endoscopic group had 2 cases of intact 
ossicles, 12 cases of eroded long processes of the incus, 5 cases of eroded malleus and 3 
cases of eroded stapes superstructures. The CWU group had 6 cases of intact ossicles, 19 
eroded long processes of incus, 8 eroded malleus and 11 eroded stapes superstructures. In the 
CWD group, all ossicles were eroded; 13 involved the long process of incus, 9 involved the 
malleus and 19 involved the stapes superstructure. Lastly for the combined group, 1 had 
intact ossicles while 3 had erosion of the long process of incus and 1 had an eroded stapes 
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superstructure. Overall, 47 patients had erosion of long processes of incus, 22 cases had an 
eroded malleus, 34 had eroded stapes superstructures, while only 9 cases had intact ossicles. 
Other interesting observations 
One hundred patients (79%) had wet ears at the time of surgery. The chorda tympani nerve 
was involved by cholesteatoma in 14% of all cases. Of those, 84% were sacrificed, with no 
recidivism observed for the sacrificed nerves regardless of surgical technique. The remaining 
16% of involved chorda tympani had cholesteatoma “peeled off”, with 100% recidivism 
observed for that group, regardless of surgical technique.  
DISCUSSION 
Looking at our retrospective study, a total of 128 cholesteatoma ear surgeries were done; 110 
patients were above 13 years and 18 children below 13 years. Eight Red Cross patients 
underwent EES, 7 had CWU, 2 had CWD and 1 had a combined technique. Overall 
recidivism rate in this population was 33% (6 of 18), of which 2 were approached 
endoscopically, 2 underwent a microscopic CWU, 1 had a CWD and 1 had combined 
endoscopic-microscopic approach. The mean postoperative hearing in this group was 40dB 
compared to a preoperative mean of 50,3 dB. In the Groote Schuur group, 23 underwent 
endoscopic approaches; 42 had a CWU, 40 had a CWD and 5 had a combined endoscopic-
microscopic approach. Overall recidivism rate for the above 13 year old group was 17% (19 
of 110). Of those, 7 were from the endoscopic group, 8 from the CWU group, 1 from CWD 
group and 3 from the combined technique group. Mean postoperative hearing was 47,4dB 
compared to a preoperative hearing of 48,4dB. The CWD technique demonstrated superior 
outcomes in both adults and children <13years. In the above 13 year old group, the EES 
approach had the same recurrence rate as CWU. While paediatric cholesteatomas have much 
higher recidivism rates compared to adults, our below 13 year old group was small to 
conclude any statistical difference between the different approaches and further research is  
required for this age group. 
Historically, the management of cholesteatoma was either approached using microscopic 
canal wall up or microscopic canal wall down techniques. The decision regarding which 
approach is used is based on a number of factors which includes: the extent of disease, 
pneumatisation of mastoid, aeration of middle ear and mastoid, reliability of patient to 
follow-up and surgeon preference1. It is well known that a canal wall up technique has a 
much higher recidivism rate compared to a canal wall down technique1. 
Recently, endoscopic ear surgeons have been advocating exclusive use of the endoscope in 
cholesteatoma surgery for disease confined to the middle ear due to lower recidivism rates 
5,8,11-17 . In our study, the endoscopic approach for cholesteatoma has comparable results in 
terms of recidivism with canal wall up mastoidectomy.  
A study by Migirov et al.5 retrospectively looked at recidivism rates in trans-meatal exclusive 
endoscopic ear surgery (EES). Thirty patients aged 9 to 75 years underwent EES eradication 
of cholesteatoma between July 2008 and May 2010. The posterior epitympanic space was 
involved with cholesteatoma in all except one ear. There was no residual disease in 18 
patients who were followed-up for >1 year, and the diffusion-weighted sequence MRI was 
negative in 3 patients. Seven additional patients were scheduled to undergo MRI within the 
next 2 to 3 months. The other 8 patients were satisfied with their clinical results, declined 
going for a follow-up MRI scan. Their preliminary results indicate that the minimally 
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invasive EES allowed complete eradication of cholesteatoma from the middle ear and its 
extensions, with minimal morbidity and good functional results. The study showed good 
results. However the follow-up period of 1 year is very short. Their results however, differ 
significantly from our EES recidivism of 28% and 30% for the < 13 year olds and > 13 year 
olds respectively, over a follow-up period of 29 months. 
Marchioni’s results8 showed a higher recidivism, with a recurrence rate of 12,9%  and a 
residual rate of 19,3% . He had a longer follow up period of 36 months compared to 
Migirov’s study above5. Of note, these were all paediatric patients treated with EES 
approach, between January 2007 and December 2013. Patients presenting with cholesteatoma 
of the tympanic cavity with no mastoid involvement were included in the first group and 
underwent EES. Patients with mastoid extension of the pathology were included in the 
control group and underwent a CWU procedure. Fifty-nine ears of 54 patients were reviewed. 
Median age was 9.6 years (range 4-16 years). Thirty-one cholesteatomas underwent an EES 
approach, while 28 underwent a CWU approach. Recurrence rates were 12.9% (4 ears) for 
the EES group and 17.2%(5 ears) for the CWU approach. Residual disease was present in 
26.6%: 19.3%(6 ears) for the EES and 34.4%(10 ears) for the CWU approach. The mean 
follow up period was 36 months (range 8-88). Kaplan-Meier analysis at 36 months showed a 
lower recurrence risk for the EES compared with the CWU approach, but this data had no 
statistical significance (P = 0.58). This is fairly similar to the findings of our  <13 year old 
group. We had a recidivism of 28% for CWU and 25% for EES over a period of 24 to 29 
months. 
Tarabichi’s study11 evaluated 8 years of experience with trans-canal endoscopic management 
of limited attic cholesteatoma. He did a case series on seventy-three ears with limited attic 
cholesteatoma that underwent endoscopic trans-canal tympanotomy and extended atticotomy 
to access and completely remove the sac. Their mean follow-up was 43 months. Only five 
ears required revision for recurrent disease (6,8%). The recidivism rate was much lower 
compared to 29% for our EES overall results . Based on his findings, he concluded that an 
endoscopic technique allows transcanal, minimally invasive, eradication of limited attic 
cholesteatoma.  
Alicandri-Ciufelli et al12 analysed only cholesteatoma treated endoscopically (exclusively or 
combined) with at least 3 years of follow-up; canal wall down procedures were excluded. The 
final study group included 244 ears in 234 patients. The mean follow-up was 64.3 months. 
166 patients (68%) free from disease post-operatively, 29 patients (12%) had recurrence, and 
49 patients (20%) had residual disease. 73 patients (30%) had a cholesteatoma limited 
exclusively to the attic, whereas 44 (18%) had also a mesotympanic extension of the disease, 
37 (15%) patients had exclusive involvement of the mesotympanum, 73 (30%) had antral 
extension, and 17 (7%) had mastoid extension. There were 41 patients (17%) who were aged 
< 18 years, and 203 (83%) were adults. A recurrence or residual was present in 68 adult 
patients (33%), and 10 recurrence or residual in 41 patients aged < 18yrs was noted (24%). 
Of 73 patients with cholesteatoma limited exclusively to the attic, 15 experienced residual 
disease; of 44 patients who also had a mesotympanic extension, 8 experienced residual 
pathology at follow-up, and of 37 patients with exclusive mesotympanic involvement, 5 
experienced residual disease. Of 73 patients with antral extension, 18 experienced residual 
pathology, and of 17 patients with mastoid extension, 3 experienced residual pathology. In 
terms of site of cholesteatoma, their paediatric findings concur with our findings of the attic 
being the commonest primary site (51%) and commonest site of recurrence (33%). Their 
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comment was that the endoscopic results were similar to those reported for classic 
microscopic techniques in terms of recurrences or residual pathology at long-term follow-up.  
Presutti et al13 assessed the result of using an endoscope in cholesteatoma surgery and 
demonstrated how it reduced the incidence of residual disease prospectively. A total of 53 
ears with a primarily acquired cholesteatoma were resected. Twenty were resected using a 
canal wall up (CWU) technique, 6 using a canal wall down (CWD) technique, and in 27 cases 
a trans-canal atticotomy was performed. All of the patients underwent explorative and 
operative endoscopic ear surgery complementary to the operating microscope to uncover and 
remove residual cholesteatoma. In the primary surgery after completion of microscopic 
cleaning, the overall incidence of intraoperative residual disease detected with the endoscope 
was 37.5%, with the sinus tympani being the most common site of intraoperative residuals, 
followed by the anterior epitympanic recess and protympanum. Out of the 20 CWU cases, 12 
second-look endoscopies were performed. Two recurrences were identified, both in the sinus 
tympani.  
Marchioni et al14 reported results of 146 ears with a mean follow-up of 31.2 months. Of the 
146 patients, 4 (2.7%) patients were diagnosed with recurrence, and 7 (4.8%) patients had 
residual disease. Of 33 patients with cholesteatoma limited exclusively to the attic, none 
experienced residual disease. Fifty-five patients had mesotympanic extension, 2 experienced 
residual pathologic condition at follow-up. Of 31 patients with antral extension, 2 
experienced residual disease, and of 23 patients with mastoid extension, 3 experienced 
residual disease. When one looks closely at his results for residual disease it would appear 
that the lowest rate of residual disease is when the cholesteatoma is confined to the attic. As 
soon the disease is more extensive the risk of leaving behind residual disease appears to be 
higher. When looking at the sites of involvement in our study, more than 60% of patients in 
the overall had more than 2 sites involved by cholesteatoma. 
Badr-el-Dine et al6 prospectively assessed the value of ear endoscopy in cholesteatoma 
surgery and whether it improves surgical outcomes. A total of 92 ears were operated on. 
Eighty two cases were operated on by using canal wall up (CWU) technique, and 10 
underwent canal wall down (CWD) procedures. Endoscopically guided ear surgery was 
incorporated complementary to the microscope. In the primary surgery after completion of 
microscopic cleaning, the overall incidence of intraoperative residuals detected with the 
endoscope was 22.8%. Sinus tympani was the most common site of intraoperative residuals 
in both CWU and CWD groups, followed by the facial recess and the under surface of the 
scutum in the CWU cases. Three recurrences (8.6%) were identified with CWU.  
Prasad et al15 did a retrospective study to evaluate the outcomes of the modified Bondy’s 
technique performed at their centre and for limited epitympanic cholesteatomas and to debate 
the  benefits of endoscopic surgery for the same indication. Two hundred and sixty nine ears 
in 258 patients with a minimum of 5-year follow-up that were operated for limited 
epitympanic cholesteatoma using the modified Bondy’s technique were included in the study. 
There were no recurrent cholesteatomas in their series. Their conclusion was that the 
modified Bondy’s technique, which provided excellent postoperative outcomes, is the surgery 
of choice for limited epitympanic cholesteatomas. They also concluded that the endoscope, 
despite its better visualization of hidden areas did not provide a distinct overall technical 
advantage or better results than the microscope. 
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The important question is: which patients are suitable for exclusive endoscopic technique? 
Following a literature search, there was no clear patient selection criteria proposed. Both 
Tarabichi et al16 and Glikson et al17 recommended endoscopic surgery when the 
cholesteatoma did not extend posterior to the anterior limb of the lateral semi-circular canal. 
These are the same criteria we use in both our centres. 
When reviewing our CT scans, we paid attention to pneumatisation and ventilation of the 
temporal bones, as we suspect this may affect recurrence rates. Studies have shown higher 
incidences of squamous disease with sclerotic mastoids and poor tubal function18. 
Other factors that impact decision making for EES such as patient reliability and preoperative 
CT scan as a requirement to assess whether disease is confined to middle ear space or 
extensive, are not adequately addressed in literature.  
 
Comparing recidivism rates between the >13 year old group and <13 year old group, findings 
in our study show that recidivism rates are higher in the <13 year old population, which 
concurs with findings in the literature, which shows that children have more  aggressive 
disease caused by continuing eustachian tube dysfunction and hence formation of new 
retraction pockets18. The peaking of recidivism in this group was eleven years. Our study also 
shows that the exclusive endoscopic approach in paediatrics has a comparable recidivism rate 
to the microscopic canal wall up procedure. One limitation of our study was that our <13 year 
old patient numbers were relatively small (n=18). Larger paediatric studies are obviously 
needed to derive a meaningful conclusion. Previous studies quoted above looking at 
cholesteatoma surgery in children reported very favourable results for limited disease.  
 
The reported advantages of endoscopy in cholesteatoma surgery is improved visualization of 
the hidden sites, and this may have an advantage in reducing residual disease especially in 
those hidden sites, which include the sinus tympani, facial recess and the attic1. We analysed 
a retrospective study by Ayache4. The objectives of the study were to evaluate otoendoscopy 
as a means of identifying residues of lesions after excision of disease under otomicroscopy in 
the same stage of surgery and its impact on the frequency of residual cholesteatomas at the 
time of surgical revision. They had 350 patients. The surgical procedures were divided into 
closed tympanoplasty via the trans-meatal approach, closed tympanoplasty with 
antroatticomastoidectomy and open tympanoplasty. Eighty patients (34%) who presented 
with an initial location of the disease at the epitympanum underwent complementary 
exploration by otovideoendoscopy. In 35 cases (44%), otoendoscopy revealed a residual 
lesion after an apparently total excision by otomicroscopy during closed tympanoplasty. In 65 
cases (76%), a residual lesion was identified by otoendoscopy during the first stage of 
surgery in the sinus tympani or on the footplate of the stapes, between the crura of the stapes. 
Analysis using otoendoscopy reduced the incidence of residual cholesteatomas by identifying 
lesion extensions that are overlooked under otomicroscopy. In this population, the frequency 
of CWD was also significantly lower. 
 
In our study, the microscopic canal wall down approach remained the most effective single 
stage procedure with the lowest recidivism, which was statistically significant (p=0.001).  
 
Our research study also shows evidence that the combined microscopic-endoscopic approach 
is the least favourable option when disease extends beyond confines of the tympanic cavity. 
Nogueira et al19 looked at outcomes of combined endoscopic-microscopic approach to 
cholesteatoma in 112 patients. Their recidivism rate was 6.8%, which is a figure almost 
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equivalent to quoted CWD surgery outcomes. Their study does not however, specify whether 
the canal wall was lowered or not.  
 
There has been a paradigm shift in the surgical approach to cholesteatoma with intent to 
restore the tympanomastoid anatomy and physiology. The endoscope no doubt allows a more 
conservative approach by providing better visualisation of hidden sites thereby enabling 
preservation of the canal wall. The aim of cholesteatoma surgery however is not only to 
eradicate disease but also reduce the risk of recurrence. While the use of the endoscope has 
been shown to reduce the rate of residual disease more studies are required which have a 
longer follow-up period to assess the risk of recurrent disease. 
 
CONCLUSION 
The key findings of our study were that the CWD technique demonstrated superior outcomes 
in both adults and children <13years. In the above 13 year old group, the EES approach had 
the same recurrence rate as CWU. While paediatric cholesteatomas have much higher 
recidivism rates compared to adults, our below 13 year old group was too small to conclude 
any statistical difference between the different approaches and further studies are required in 
this age group.  
Based on our data, the choice of appropriate surgical technique should depend on a balance 
between extent of disease, anatomical favourability, radiological factors and patient 
reliability. We recommend pre-operative CT scan to assess extent of disease to aid in 
decision making regarding the most appropriate surgical method to use. To reduce risk 
factors for recidivism, we advise having a low threshold for taking down the canal wall when 
disease extends into the mastoid. Although the surgeon's personal preference and experience 
should also be taken into consideration, an individualized approach must be adopted for all 
patients. 
LIMITATIONS 
? In the group below 13 years of age, we had a limited number of patients, statistically, 
it was not possible to make meaningful conclusions. 
? Grouping of participants according to age above or below 13 was due to our two 
referral hospitals, Red Cross and Groote Schuur, using 13 years as a cut-off age for 
referring and managing patients. Below 13 year old are seen at Red Cross only, while 
those above 13 are referred and managed only in Groote Schuur Hospital. 
? Disease extension differed across all 4 study groups, meaning cholesteatomas were 
not confined to the same sites, this was noted as a potential limitation of the study. 
SUGGESTIONS FOR FURTHER RESEARCH 
Studies with a long-term follow up and larger cohort studies are necessary to definitively 
validate the outcomes of the different techniques in cholesteatoma surgery, for a more 
meaningful conclusion. Studies looking at correct patient selection for the different surgical 
method would add quality and standardized approaches. None of the papers considered in this 
study were randomized trials, so there is always room for bias.  
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Section 1 Description of all participants (>13 and <13 age groups) 
Table 1.1 Baseline Characteristics of the all Study Participants 
Characteristic Endoscopic CWU CWD Combined Total 
Total ears 31 (24.2%) 49 (38.3%) 42 (32.8%) 6 (4.7%) 128 
Sex 
 Male 15 (48.4%) 19 (38.8%) 21 (50.0%) 5 (83.3%) 60 (46.9%) 
 Female 16 (51.6%) 30 (61.2%) 21 (50.0%) 1 (16.7%) 68 (53.1%) 
Side of ear 
 Right 15 (48.4%) 31 (63.3%) 19 (45.2%) 2 (33.3%) 67 (52.3%) 
 Left 16 (51.6%) 18 (36.7%) 23 (54.8%) 4 (66.7%) 61 (47.7%) 
Unilateral/bilateral 
 Unilateral 31 (100.0%) 49 (100.0%) 42 (100.0%) 6 (100.0%) 128 (100.0%) 
 Bilateral 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Numbers per surgical technique 
>13 age group 23 (74.2%) 42 (85.7%) 40 (95.2%) 5 (83.3%) 110 (85.9%) 
<13 age group 8 (25.8%) 7 (14.3%) 2 (4.8%) 1 (16.7%) 18 (14.1%) 
Table 1.2 Site of Cholesteatoma in combined >13 and <13 age group participants 
Site Endoscopic CWU CWD Combined Total  
Attic 25 (80.6%) 22 (44.9%) 14 (33.3%) 5 (83.3%) 66 (51.6%) 
Extension into 
sinus tympani 
12 (38.7%) 13 (26.5%) 7 (16.7%) 1 (16.7%) 33 (25.8%) 
Extension into 
facial recess 
7 (22.6%) 7 (14.3%) 4 (9.5%) 1 (16.7%) 19 (14.8%) 
Extension into 
Prussak's space 
4 (12.9%) 14 (28.6%) 1 (2.4%) 0 (0.0%) 19 (14.8%) 
Extension into 
hypotympanum 
0 (0.0%) 2 (4.1%) 2 (4.8%) 0 (0.0%) 4 (3.1%) 
Extension into 
mastoid 
5 (16.1%) 16 (32.7%) 27 (64.3%) 6 (100.0%) 54 (42.2%) 
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Figure 1.1 Site of cholesteatoma in both >13 and <13 age group participants 
Figure 1.2 Site of cholesteatoma in the participants > 13 years 
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Table 1.3 Site of Cholesteatoma in >13 year age group participants 
Site Endoscopic CWU CWD Combined Total  
Attic 18 (78.3%) 22 (52.4%) 14 (35.0%) 4 (80.0%) 58 (52.7%) 
Extension into 
Sinus Tympani 
8 (34.8%) 9 (21.4%) 7 (17.5%) 1 (20.0%) 25 (22.7%) 
Extension into 
Facial Recess 
5 (21.7%) 6 (14.3%) 3 (7.5%) 1 (20.0%) 15 (13.6%) 
Extension into 
Prussak’s Space 
4 (17.4%) 13 (31.0%) 1 (2.5%) 0 (0.0%) 18 (16.4%) 
Extension into 
Hypotympanum 
0 (0.0%) 2 (4.8%) 2 (5.0%) 0 (0.0%) 4 (3.6%) 
Extension into 
Mastoid 
3 (13.0%) 13 (31.0%) 26 (65.0%) 5 (100.0%) 47 (42.7%) 
Figure 1.3 Site of Cholesteatoma in <13 age group participants 
Table 1.4 Site of Cholesteatoma in <13 year age group participants 
Site Endoscopic CWU CWD Combined Total  
Attic 7 (87.5%) 0 (0%) 0 (0%) 1 (100.0%) 8 (44.4%) 
Extension into 
Sinus Tympani 
4 (50.0%) 4 (57.1%) 0 (0%) 0 (0%) 8 (44.4%) 
Extension into 
Facial Recess 
2 (25.0%) 1 (14.3%) 1 (50.0%) 0 (0%) 4 (22.2%) 
Extension into 
Prussak’s Space 
0 (0%) 1 (14.3%) 0 (0%) 0 (0%) 1 (5.6%) 
Extension into 
Hypotympanum 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Extension into 
Mastoid 
2 (25.0%) 3 (42.9%) 1 (50.0%) 1 (100.0%) 7 (38.9%) 
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Section 2 Outcomes (Recidivism rate) 
Table 2.1 Outcomes by surgical intervention in combined >13 and <13 age group patients 
Site Endoscopic CWU CWD Combined Total  
Recidivism rate 9 (29.0%) 10 (20.4%) 2 (4.8%) 4 (66.7%) 25 (19.5%) 
Site of recidivism 
  Attic 3 (33.3%) 4 (40.0%) 1 (50.0%) 1 (25.0%) 9 (36.0%) 
Extension Sinus 
Tympani 
2 (22.2%) 2 (20.0%) 0 (0.0%) 0 (0.0%) 4 (16.0%) 
Extension into 
Facial Recess 
0 (0.0%) 3 (30.0%) 1 (50.0%) 0 (0.0%) 4 (16.0%) 
Extension into 
Prussak’s Space 
1 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (4.0%) 
Extension into 
Hypotympanum 
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Extension into 
Mastoid 
3 (33.3%) 1 (10.0%) 0 (0.0%) 3 (75.0%) 7 (28.0%) 
Figure 2.1 Overall Recurrence rate by surgical technique in >13 and <13 age group 
participants (Overall rate =19.5%) 
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Table 2.2 Outcomes by surgical intervention in >13 age group participants 
Site Endoscopic CWU CWD Combined Total  
Recurrence 7 (30.4%) 8 (19.0%) 1 (2.5%) 3 (60.0%) 19 (17.3%) 
Site of recurrence 
Attic 3 (42.9%) 3 (37.5%) 1 (100.0%) 0 (0.0%) 7 (36.8%) 
Extension into 
Sinus Tympani 
1 (14.3%) 2 (25.0%) 0 (0.0%) 0 (0.0%) 3 (15.8%) 
Extension into 
Facial Recess 
0 (0.0%) 3 (37.5%) 0 (0.0%) 0 (0.0%) 3 (15.8%) 
Extension into 
Prussak’s Space 
1 (14.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (5.3%) 
Extension 
Hypotympanum 
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
  Mastoid 2 (28.6%) 0 (0.0%) 0 (0.0%) 3 (100.0%) 5 (26.3%) 
Figure 2.2 Overall Recurrence rate in >13 age group participants by surgical technique 
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Table 2.3 Outcomes by surgical intervention in <13 age group participants 
Site Endoscopic CWU CWD Combined Total  
Recurrence 2 (25.0%) 2 (28.0%) 1 (50.0%) 1 (100.0%) 6 (33.3%) 
Site of recurrence 
Attic 0 (0.0%) 1 (50.0%) 0 (0.0%) 1 (100.0%) 2 (33.0%) 
Extension into 
Sinus Tympani 
1 (50.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (16.7%) 
Extension into 
Facial Recess 
0 (0.0%) 0 (0.0%) 1 (100.0%) 0 (0.0%) 1 (16.7%) 
Extension into 
Prussak’s Space 
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Extension into 
Hypotympanum 
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Extension into 
mastoid 
1 (50.0%) 1 (50.0%) 0 (0.0%) 0 (0.0%) 2 (33.0%) 
Figure 2.3 Overall Recurrence rate in the <13 age group participants by surgical technique 
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Section 3 Hearing Outcomes 
Table 3.1 Pre and post-operative hearing outcomes by intervention group 
Mean scores ENDOSCOPIC CWU CWD COMBINED TOTAL 
>13
group
Pre Op Audio 
dB 
49.0 48.0 45.8 51.0 48.4 
Post Op Audio 
dB 
42.6 43.1 41.6 54.0 47.4 
Delta 6.4 4.9 4.2 -3.0 1.0 
Below 13 
group 
Pre Op Audio 
dB 46.3 45 60 50 50.3 
Post Op Audio 
dB 30.6 42 42.5 45 40 
Delta 15.7 3.0 17.5 5.0 10.3 
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DATA CAPTURE SHEET   
RESEARCH STUDY: A RETROSPECTIVE AUDIT OF OUTCOMES OF ENDOSCOPIC 
CHOLESTEATOMA EAR SURGERY 
DEMOGRAPHICS 
Study number Folder number 
Date of birth Gender Male? Female ? 
Total number of cholesteatoma surgeries 1? 2? 3? 4?          
Primary Surgery 
Side operated 
R?         L? 
Date of 
operation 
Endoscopic? Microscopic 
CWU?    
CWD? 
Combined? Chorda Tympani involved 
Yes? No? 
If yes:  Preserved?       Sacrificed? 
1st Revision  
Side operated 
R?         L? 
Date of 
operation 
Endoscopic? Microscopic 
CWU?    
CWD? 
Combined? Chorda Tympani involved 
Yes? No? 
If yes:  Preserved?       Sacrificed? 
2nd Revision  
Side operated 
R?         L? 
Date of 
operation 
Endoscopic? Microscopic 
CWU?    
CWD? 
Combined? Chorda Tympani involved 
Yes? No? 
If yes:  Preserved?       Sacrificed? 
3rd Revision 
Side operated 
R?         L? 
Date of 
operation 
Endoscopic? Microscopic 
CWU?    
CWD? 
Combined? Chorda Tympani involved 
Yes? No? 
If yes:  Preserved?       Sacrificed? 
PREOPERATIVE OTOLOGIC FINDINGS 
Site of cholesteatoma 
State of ear Wet         ? Dry ? 
Tympanic membrane Intact      ? Perforated    ? 
Ossicular chain Intact      ? Eroded          ? 
State of middle ear mucosa 
Preoperative complications Non         ? Extratemporal   ?   
State: 
Intratemporal   ? 
State: 
AUDIOLOGICAL ASSESSMENT 
Preop Audio 3months 
Postop audio  
6months 
Postop audio  
12months 
Postop 
audio  
18months 
Postop 
audio  
Bone conduction 
(BC) 
BC BC  BC  BC
Pure tone average 
(PTA) 
PTA PTA  PTA  PTA
Speech reception 
threshold (SRT) 
SRT SRT  SRT  SRT
IMAGING 
Preoperative CT 
temporal bone 
Done before primary procedure ? Postop CT  
Done before revision surgery      ? 
Site of 
cholesteatoma 
Residual disease/ Recurrent
disease & site 
Integrity of ossicular 
chain 
Integrity of ossicular chain 
Pneumatization of 
mastoid 
Pneumatization of mastoid 
State of middle ear State of middle ear
Ventilation Ventilation
Disease 
complications 
Disease complications
Post primary surgery  clinical findings 
36 
Recurrent/ residual  disease Yes ? 
Site: 
No ? 
Tympanic Membrane Intact? Perforation? 
Cavity Wet? Mucosalized? Epithelialized? 
Iatrogenic complications:    Present?           Absent? Details
Post 1st revision surgery  clinical findings 
Recurrent/ residual  disease Yes ? 
Site: 
No ? 
Tympanic Membrane Intact? Perforation? 
Cavity Wet? Mucosalized? Epithelialized? 
Iatrogenic complications:    Present?           Absent? Details
Post 2nd revision surgery  clinical findings 
Recurrent/ residual  disease Yes ? 
Site: 
No ? 
Tympanic Membrane Intact? Perforation? 
Cavity Wet? Mucosalized? Epithelialized? 
Iatrogenic complications:    Present?           Absent? Details
Post 3rd revision surgery  clinical findings 
Recurrent/ residual  disease Yes ? 
Site: 
No ? 
Tympanic Membrane Intact? Perforation? 
Cavity Wet? Mucosalized? Epithelialized? 
Iatrogenic complications:    Present?           Absent? Details
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